Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000236600 | SCV000255685 | pathogenic | not provided | 2017-09-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000236600 | SCV000293529 | pathogenic | not provided | 2018-09-20 | criteria provided, single submitter | clinical testing | The R280H missense variant in the MFN2 gene has been reported previously in association with both early onset and late onset Charcot-Marie-Tooth disease type 2A (Zuchner et al., 2004; Verhoeven et al., 2006; Liesa et al., 2009), and the R280 position is considered a mutational hotspot (Verhoeven et al., 2006; Liesa et al., 2009). Functional studies of the R280H variant demonstrate a damaging effect with lack of mitochondrial fusion activity (Detmer et al., 2007). The R208H variant is not observed in large population cohorts (Lek et al., 2016). We interpret R280H as a pathogenic variant. |
Invitae | RCV000549934 | SCV000657731 | pathogenic | Charcot-Marie-Tooth disease, type 2 | 2019-11-15 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with histidine at codon 280 of the MFN2 protein (p.Arg280His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs28940294, ExAC 0.002%). This variant has been reported in individuals affected with Charcot-Marie-Tooth disease, type 2A (PMID: 15064763, 27549087, 16714318, 24957169, 22492563, 21149811, 27027447, 27088055) and has been reported to segregate with disease in multiple families (PMID: 15064763, 16835246). ClinVar contains an entry for this variant (Variation ID: 2271) Experimental studies have shown that this variant affects the proper transport of mitochondria by the MFN2 protein in neurons (PMID: 17296794, 17215403). For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV000002359 | SCV001149834 | pathogenic | Charcot-Marie-Tooth disease, type 2A2A | 2019-04-05 | criteria provided, single submitter | clinical testing | |
Kariminejad - |
RCV000002359 | SCV001167080 | pathogenic | Charcot-Marie-Tooth disease, type 2A2A | criteria provided, single submitter | clinical testing | ||
Molecular Genetics Laboratory, |
RCV000789418 | SCV001336792 | pathogenic | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Institute of Medical Genetics and Applied Genomics, |
RCV000236600 | SCV001447019 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000002359 | SCV000022517 | pathogenic | Charcot-Marie-Tooth disease, type 2A2A | 2006-08-01 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium | RCV000789418 | SCV000928773 | pathogenic | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |